Levetiracetam
CAS No. 102767-28-2
Levetiracetam( UCB L059 )
Catalog No. M10134 CAS No. 102767-28-2
Levetiracetam(UCB L059) is a novel anticonvulsant with antihyperalgesic efficacy in inflammatory pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 42 | In Stock |
|
| 50MG | 54 | In Stock |
|
| 100MG | 91 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 238 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLevetiracetam
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevetiracetam(UCB L059) is a novel anticonvulsant with antihyperalgesic efficacy in inflammatory pain.
-
DescriptionLevetiracetam(UCB L059) is a novel anticonvulsant with antihyperalgesic efficacy in inflammatory pain.(In Vitro):Levetiracetam increases the transcription of HDACs and recruits corepressor complex on O6-Methylguanine-DNA-methyltransferase (MGMT) promoter, thus silencing its activity.Levetiracetam sensitizes (40 μg/mL) glioblastoma multiforme stem-like cells (GSCs) to Temozolomide (250 μM) treatment.MGMT expression is downregulated in GCSCs treated with Levetiracetam (40 μg/mL)(In Vivo):Levetiracetam (10, 25, or 50 mg/kg) suppresses behavioral and electrographic seizure activity during neonatal hypoxia.
-
In Vitro——
-
In VivoAnimal Model:Male Long-Evans ratsDosage:10, 25, or 50?mg/kg Administration:Intraperitoneal injection 60?min before hypoxia. Result:Treatment resulted in a significant decrease in hypoxic seizure (HS) duration at 25?mg/kg and at 50?mg/kg. Anti convulsant activity was maximal at 50?mg/kg, at which HSs were reduced by 63.6%.
-
SynonymsUCB L059
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel| Synaptic vesicle glycoprotein 2A
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number102767-28-2
-
Formula Weight170.21
-
Molecular FormulaC8H14N2O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 34 mg/mL (199.75 mM); Water: 34 mg/mL (199.75 mM); DMSO: 34 mg/mL (199.75 mM)
-
SMILESO=C(N)[C@H](CC)N1C(CCC1)=O
-
Chemical Name(S)-2-(2-oxopyrrolidin-1-yl)butanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Yangambin
Yangambin is a selective antagonist of the cardiovascular effects of platelet activating factor (PAF); it has hypotensive effect, which is probably due to a peripheral vasodilatation that involves, at least, the inhibition the Ca2+ influx through voltage-gated Ca2+ channels. Yangambin has central nervous system activity, it presents a depressant activity in the open field, forced swimming and pentobarbital sleeping time tests.
-
Cronidipine
Cronidipine (LF 20254), a calcium channel antagonist, is used potentially for the treatment of hypertension and myocardia ischemia.
-
Azumolene
Azumolene1.EU4093 (azumolene sodium) is a direct acting, skeletal muscle relaxant with structural similarities to dantrolene sodium in that the para-nitro phenyl group of dantrolene sodium is replaced by a para-bromo phenyl group.?2.?The effect of EU4093 on the twitch of the intact rat soleus preparation is nearly maximal at a dose of 20 mg kg-1.?
Cart
sales@molnova.com